Skip to main content

Table 6 ASTRO and GEC-ESTRO suitable patient recommendation selections for APBI outside of clinical trials

From: Accelerated Partial Breast Irradiation (APBI): A review of available techniques

 

Suitable group by ASTRO [138]

Low Risk group by GEC-ESTRO [137]

Factors

Criterion

Criterion

Age

> 60 y

> 50

BRCA 1, 2 Mutation

Not present

na

Tumor Size

< 2 cm

< 3 cm

T stage

T1

T1-2

Margins

Negative by at least 2 mm

Negative by at least 2 mm

Grade

any

any

LVSI

Not allowed

Not allowed

ER status

positive

any

Multicentricity

unicentric

unicentric

Multifocality

Unifocal with total size of < 2 cm

unifocal

Histology

IDC, mucinous, tubular and colloid

IDC, mucinous, medullary, colloid

DCIS

Not allowed

Not allowed

EIC

Not allowed

Not allowed

Associated LCIS

Allowed

Allowed

Nodal status

pN0 (by SN Bx or ALND

pN0 (by SLNB or ALND)

Neoadjuvant Therapy

Not allowed

Not allowed

  1. APBI = accelerated partial breast irradiation, IDC = invasive ductal carcinoma, ILC = invasive lobular carcinoma, LCIS = lobular carcinoma in situ; DCIS = ductal carcinoma in situ; EIC = extensive intraductal component; LVI = lympho-vascular invasion; ER = estrogen receptor; SLNB = sentinel lymph node biopsy; ALND = axillary lymph node dissection